Jiang L, Tang K, Levin M, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20: e276–88—In this Review, the fourth sentence of the fourth paragraph in the COVID-19 pathophysiology and link with MIS-C section should have read “…Gruber and colleagues91 have reported that patients with MIS-C had neutralising antibodies against SARS-CoV-2, which are associated with interleukin-18 (IL-18) and IL-6 activation…”. This correction has been made to the online version as of Aug 5, 2022.
. 2022 Aug 5;22(10):e279. doi: 10.1016/S1473-3099(22)00530-8
Correction to Lancet Infect Dis 2020; 20: e276–88
Issue date 2022 Oct.
© 2022 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9355460 PMID: 35940181
This corrects the article "COVID-19 and multisystem inflammatory syndrome in children and adolescents" in volume 20 on page e276.